|
Re: So many questions...
|
3
|
Resverlogix Corp.
|
Dec 07, 2019 07:44AM
|
|
Re: Thar she blows!
|
3
|
Resverlogix Corp.
|
May 21, 2021 06:40PM
|
|
Re: Question re ALP
|
2
|
Resverlogix Corp.
|
Dec 16, 2019 05:12PM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 09:47AM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 09:56AM
|
|
Re: I wonder...
|
2
|
Resverlogix Corp.
|
Jan 23, 2020 04:00PM
|
|
Re: A non-rose coloured view of the Webcast
|
2
|
Resverlogix Corp.
|
Nov 02, 2019 02:09PM
|
|
Re: what's this mean exactly?
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 01:57PM
|
|
Re: Diabetes, dementia, and ABL
|
2
|
Resverlogix Corp.
|
Dec 22, 2019 02:32PM
|
|
Re: No word on...
|
2
|
Resverlogix Corp.
|
Jul 15, 2021 07:43PM
|
|
Re: Congestive heart failure
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 07:04PM
|
|
Re: IP considerations may prevent RVX from disclosing eGFR data
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 01:06PM
|
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 27, 2019 11:14AM
|
|
Re: What an incredible...
|
2
|
Resverlogix Corp.
|
Dec 22, 2019 04:09PM
|
|
Re: Q4 2019 Events
|
2
|
Resverlogix Corp.
|
Oct 02, 2019 07:09AM
|
|
Re: Tweet from Prof Kausik Ray
|
2
|
Resverlogix Corp.
|
Jun 01, 2020 07:56PM
|
|
Re: Presentation is over
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 01:19PM
|
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 04:04PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
2
|
Resverlogix Corp.
|
Jun 14, 2020 05:05PM
|
|
Re: As Pfizer charges ahead....
|
2
|
Resverlogix Corp.
|
Sep 03, 2021 06:23PM
|
